ScreenerHero

FTRE Fortrea Holdings Inc.

NAS · US · Healthcare · Biotechnology · fortrea.com
20.56USD-1.06%Mkt Cap: 1.96B $P/E: —

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers cli…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.96B USD
Enterprise Value2.93B USD
Revenue (TTM)2.68B USD
Gross Profit503.80M USD
Net Income (TTM)-986.20M USD
Revenue/Share28.75 USD
Last Price20.56 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)18.15
PEG0.34
EV/EBITDA29.76
EV/Revenue1.09
P/S0.74
P/B3.77
EPS (TTM)-0.90
EPS (Forward)1.14
52W Range
8.30581% of range23.51
52W High23.51 USD
52W Low8.305 USD
Profitability
Gross Margin18.50%
Oper. Margin2.58%
EBITDA Margin3.67%
Profit Margin-36.21%
ROE-175.01%
ROA-36.31%
Growth
Revenue Growth-4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF113.50M USD
CapEx (TTM)25.20M USD
FCF Margin10.42%
FCF Yield14.26%
Net Debt949.20M USD
Net Debt/EBITDA9.66
Balance Sheet
Debt/Equity1.98
Current Ratio0.96
Quick Ratio0.85
Book Value/Sh5.51 USD
Cash/Share1.77 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.83 USD
Upside (mean)+1.3%
Target Range13.00 USD – 26.00 USD
13.00+1.3% to mean26.00
# Analysts12
Ownership
Shares Out.95.10M
Float93.98M
Insiders1.23%
Institutions108.34%
Short Interest
Short Ratio11.0d
Short % Float15.50%
Short % Out.13.20%
Shares Short12.55M
Short (prev mo.)11.50M
Technical
SMA 5018.84 (+9.1%)
SMA 20015.21 (+35.2%)
Beta1.91
S&P 52W Chg16.45%
Avg Vol (30d)1.33M
Avg Vol (10d)1.42M
Technical Indicators
RSI (14)59.1
MACD0.5961
MACD Signal0.4890
MACD Hist.+0.1071
BB Upper22.10 USD
BB Middle19.33 USD
BB Lower16.56 USD
BB Width28.69%
ATR (14)1.137 USD
Vol Ratio (20d)1.44x